This inventor holds 2 USPTO granted patents. Top assignees: Sato Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co.. Active years: 1989-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yokohama, JP (1989)
- Shinagawa, JP (1995)
Company Filing History:
Years Active: 1989-1995
Title: Shigeo Morioka: Innovator in Pharmaceutical Preparations
Introduction
Shigeo Morioka is a notable inventor based in Shinagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid and external preparation compositions. With a total of 2 patents, his work has had a meaningful impact on medical treatments.
Latest Patents
Morioka's latest patents include an aqueous suspension of sucralfate and an external preparation composition. The aqueous suspension of sucralfate is designed to provide a stable liquid pharmaceutical preparation that protects ulcer areas on mucous membranes of the stomach and duodenum. This invention is particularly noteworthy as it offers a liquid form of a treatment that has traditionally been available only in solid forms. The external preparation composition contains Ratanhia extract and/or Ratanhiaphenol, which exhibits antibacterial and antifungal properties, making it effective against pathogenic bacteria and fungi that cause skin infections.
Career Highlights
Throughout his career, Morioka has worked with prominent companies in the pharmaceutical industry, including Sato Pharmaceutical Co., Ltd. and Chugai Pharmaceutical Co. These experiences have allowed him to refine his expertise and contribute to innovative solutions in healthcare.
Collaborations
Morioka has collaborated with notable colleagues such as Taizo Okada and Masahide Katayama. Their joint efforts have further advanced the development of effective pharmaceutical products.
Conclusion
Shigeo Morioka's contributions to the pharmaceutical field through his patents and collaborations highlight his role as an innovator. His work continues to influence the development of effective treatments for various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile